KINDSTAR GLOBAL (09960) Sets 27 March 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal

Bulletin Express

Mar 17

Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL, stock code 09960) has notified the market that its board of directors will convene on 27 March 2026. The agenda includes:

• Reviewing and approving the Group’s consolidated financial results for the year ended 31 December 2025. • Authorising the publication of the FY 2025 final results. • Considering a recommendation for a final dividend, if any. • Addressing other routine corporate matters.

The meeting notice was signed by Chairman Dr. Huang Shiang and dated 17 March 2026. The current Board comprises three executive directors (Dr. Huang Shiang, Mr. Tu Zanbing, Ms. Chai Haijie), three non-executive directors (Mr. Huang Zuie-Chin, Mr. Peng Wei, Ms. Huang Lu) and three independent non-executive directors (Dr. Yao Shanglong, Dr. Xia Xinping, Mr. Gu Huaming).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1119933102"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1119933102\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1119933102?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-17 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119933102","market":"us","top_or_hot":-1,"title":"KINDSTAR GLOBAL (09960) Sets 27 March 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL, stock code 09960) has notified the market that its board of directors will convene on 27 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the Group’s consolidated financial results for the year ended 31 December 2025.  \n• Authorising the publication of the FY 2025 final results.  \n• Considering a recommendation for a final dividend, if any.  \n• Addressing other routine corporate matters.</p>\n<p>The meeting notice was signed by Chairman Dr. Huang Shiang and dated 17 March 2026. The current Board comprises three executive directors (Dr. Huang Shiang, Mr. Tu Zanbing, Ms. Chai Haijie), three non-executive directors (Mr. Huang Zuie-Chin, Mr. Peng Wei, Ms. Huang Lu) and three independent non-executive directors (Dr. Yao Shanglong, Dr. Xia Xinping, Mr. Gu Huaming).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KINDSTAR GLOBAL (09960) Sets 27 March 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKINDSTAR GLOBAL (09960) Sets 27 March 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-17 20:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL, stock code 09960) has notified the market that its board of directors will convene on 27 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the Group’s consolidated financial results for the year ended 31 December 2025.  \n• Authorising the publication of the FY 2025 final results.  \n• Considering a recommendation for a final dividend, if any.  \n• Addressing other routine corporate matters.</p>\n<p>The meeting notice was signed by Chairman Dr. Huang Shiang and dated 17 March 2026. The current Board comprises three executive directors (Dr. Huang Shiang, Mr. Tu Zanbing, Ms. Chai Haijie), three non-executive directors (Mr. Huang Zuie-Chin, Mr. Peng Wei, Ms. Huang Lu) and three independent non-executive directors (Dr. Yao Shanglong, Dr. Xia Xinping, Mr. Gu Huaming).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09960","symbol_name":"康圣环球","start_time":0,"source_url":"","article_id":"1119933102","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119933102","pubTimestamp":1773751366,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL, stock code 09960) has notified the market that its board of directors will convene on 27 March 2026. The agenda includes: • Reviewing and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09960":"康圣环球"},"translate_title":"康圣环球(09960)定于2026年3月27日召开董事会批准2025财年业绩及末期股息建议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09960":1},"content_text":"Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL, stock code 09960) has notified the market that its board of directors will convene on 27 March 2026. The agenda includes:\n• Reviewing and approving the Group’s consolidated financial results for the year ended 31 December 2025.  \n• Authorising the publication of the FY 2025 final results.  \n• Considering a recommendation for a final dividend, if any.  \n• Addressing other routine corporate matters.\nThe meeting notice was signed by Chairman Dr. Huang Shiang and dated 17 March 2026. The current Board comprises three executive directors (Dr. Huang Shiang, Mr. Tu Zanbing, Ms. Chai Haijie), three non-executive directors (Mr. Huang Zuie-Chin, Mr. Peng Wei, Ms. Huang Lu) and three independent non-executive directors (Dr. Yao Shanglong, Dr. Xia Xinping, Mr. Gu Huaming).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}